Momenta Phama (MNTA) Chief Medical Officer, SVP Roach Resigns

October 19, 2016 8:40 AM EDT
Get Alerts MNTA Hot Sheet
Trade MNTA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Momenta Phama (NASDAQ: MNTA) disclosed the following in a U.S. SEC filing on Wednesday:

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 17, 2016, James M. Roach, M.D., informed Momenta Pharmaceuticals, Inc. (the “Company”) of his intention to resign from his roles as the Company's Senior Vice President, Development and Chief Medical Officer, effective on or around November 29, 2016.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Hot Corp. News, Management Changes

Add Your Comment